Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Eva Marie Jacobsen"'
Autor:
Nina Haagenrud Schultz, Pål Andre Holme, Stine Bjørnsen, Carola Elisabeth Henriksson, Per Morten Sandset, Eva-Marie Jacobsen
Publikováno v:
Platelets, Vol 31, Iss 1, Pp 43-47 (2020)
Factor Xa inhibitors are safe and effective alternatives to warfarin, but several studies indicate that rivaroxaban may cause a different risk profile for bleeding. For instance, while the risk of major bleeding in general may be lower with rivaroxab
Externí odkaz:
https://doaj.org/article/06d2a660183045189d5073ccaf09412f
Publikováno v:
Case Reports in Obstetrics and Gynecology, Vol 2021 (2021)
Pregnancy is associated with an increased risk of venous thromboembolism (VTE). Previous VTE and severe thrombophilia are important risk factors. Our case was a 36-year-old woman, gravida 6, para 0, with antithrombin (AT) deficiency caused by a homoz
Externí odkaz:
https://doaj.org/article/7e55ef0be70a481d98aa98cef6492853
Autor:
Ida Kathrine Gravensteen, Eva-Marie Jacobsen, Per Morten Sandset, Linda Bjørk Helgadottir, Ingela Rådestad, Leiv Sandvik, Øivind Ekeberg
Publikováno v:
BMC Pregnancy and Childbirth, Vol 18, Iss 1, Pp 1-10 (2018)
Abstract Background Experiencing a stillbirth can be a potent stressor for psychological distress in the subsequent pregnancy and possibly after the subsequent birth. The impact on women’s relationship with her partner in the subsequent pregnancy a
Externí odkaz:
https://doaj.org/article/1f7306a5d9384222bedbb402052c8e95
Autor:
Trine-Lise Larsen, Marte Svalastoga, Jorunn Brekke, Tone Enden, Hege Frøen, Herish Garresori, Eva Marie Jacobsen, Petter Quist Paulsen, Alina Carmen Porojnicu, Anne Hansen Ree, Dag Torfoss, Elin Osvik Velle, Hilde Skuterud Wik, Waleed Ghanima, Per Morten Sandset, Anders Erik Astrup Dahm
Publikováno v:
Thrombosis Research.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9e02a7a3f59e2a3b45382967b4dfa6a
https://doi.org/10.1016/j.thromres.2023.05.017
https://doi.org/10.1016/j.thromres.2023.05.017
Autor:
Anders Erik Astrup Dahm, Dag Torfoss, Eva-Marie Jacobsen, Hege Frøen, Per Morten Sandset, Waleed Ghanima, Trine-Lise Larsen
Publikováno v:
Tidsskrift for Den norske legeforening.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ca639bb37fe795a4384234037ac80d0e
https://doi.org/10.4045/tidsskr.22.0228
https://doi.org/10.4045/tidsskr.22.0228
Autor:
Ioannis Panagopoulos, Ludmila Gorunova, Eva-Marie Jacobsen, Kristin Andersen, Francesca Micci, Sverre Heim
Publikováno v:
PLoS ONE, Vol 13, Iss 4, p e0196181 (2018)
Leukemic cells often carry chromosome aberrations which generate chimeric genes of pathogenetic, diagnostic, and prognostic importance. New rearrangements giving rise to novel fusion genes define hitherto unrecognized genetic leukemia subgroups. G-ba
Externí odkaz:
https://doaj.org/article/b19cc9729f3643218e176b4e62f1c8f3
Autor:
Trine-Lise Larsen, Jorunn Brekke, Herish Garresori, Hege Frøen, Eva-Marie Jacobsen, Dag Torfoss, Hilde Skuterud Wik, Tone Ronnaug Enden, Alina Carmen Porojnicu, Petter Quist-Paulsen, Elin Velle, Per Morten Sandset, Anne Hansen Ree, Anders E.A. Dahm
Publikováno v:
Blood. 140:11366-11367
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b32af0d2e8d352095c569370faf9659b
https://doi.org/10.1182/blood-2022-160363
https://doi.org/10.1182/blood-2022-160363
Autor:
Trine‐Lise Larsen, Herish Garresori, Jorunn Brekke, Tone Enden, Hege Frøen, Eva Marie Jacobsen, Petter Quist‐Paulsen, Alina Carmen Porojnicu, Anne Hansen Ree, Dag Torfoss, Elin Osvik Velle, Hilde Skuterud Wik, Waleed Ghanima, Per Morten Sandset, Anders Erik Astrup Dahm
Publikováno v:
Journal of thrombosis and haemostasis : JTHREFERENCE. 20(8)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::613d6ccc279ba63d1439aba271b4988b
https://pubmed.ncbi.nlm.nih.gov/35859279
https://pubmed.ncbi.nlm.nih.gov/35859279
Autor:
Stine Bjørnsen, Per Morten Sandset, Nina Haagenrud Schultz, Carola E. Henriksson, Eva-Marie Jacobsen, Pål Andre Holme
Publikováno v:
Platelets. 31:43-47
Factor Xa inhibitors are safe and effective alternatives to warfarin, but several studies indicate that rivaroxaban may cause a different risk profile for bleeding. For instance, while the risk of major bleeding in general may be lower with rivaroxab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a4321f146f3cb968949ac69c725baa8
https://doi.org/10.1080/09537104.2018.1557618
https://doi.org/10.1080/09537104.2018.1557618
Autor:
Per Morten Sandset, Petter Quist Paulsen, Anne Hansen Ree, Elin Osvik Velle, Waleed Ghanima, Herish Garresori, Trine-Lise Hannevik, Anders E.A. Dahm, Hege Frøen, Eva Marie Jacobsen, Tone Enden, Jorunn Brekke, Hilde Skuterud Wik, Alina Carmen Porojnicu, Dag Torfoss
Publikováno v:
Thrombosis research. 196
Introduction The direct oral anti-coagulants (DOAC) edoxaban and rivaroxaban are suggested treatment alternatives for cancer-associated venous thromboembolism (VTE) together with low molecular-weight heparins. New studies indicate that the DOAC apixa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf0e41b1d370e3247834d1d5a8d75625
https://pubmed.ncbi.nlm.nih.gov/32919178
https://pubmed.ncbi.nlm.nih.gov/32919178